Ananta Medicare Ukraine participated in the First International Medical Forum «From Theory to Practice»

 The scientific heritage of Professor Filippov on the development of modern clinical medicine".

On June 26, 2024, "Ananta Medicare Ukraine" participated in the First Medical Forum dedicated to the memory of the prominent scientist, doctor, and educator, Professor Yuri Filippov. The event focused on the Standards of Diagnosis and Treatment of Internal Organ Diseases. The conference was attended by doctors from various specialties, including therapy, general practice-family medicine, gastroenterology, dietetics, cardiology, pulmonology, surgery, and many others.

A captivating presentation on "Gut Microbiota and Its Role in the Development of Digestive Organ Damage" was delivered by Doctor of Medical Sciences, Professor Sіrchak Y.S. The professor highlighted the critical issue of gut microbiome health and its impact on vital body functions. A particular focus was placed on the problem of dysbiosis, in particular the causes, pathogenesis, and correction methods, including the intake of probiotic products playing a leading role. Lotardi-A is a modern probiotic complex with a unique composition. It contains Saccharomyces boulardii and nine types of live lacto- and bifidobacteria, including Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus rhamnosus, Enterococcus faecium, Lactobacillus salivarius, Lactobacillus plantarum, Bifidobacterium bifidum, Bifidobacterium lactis, and Bifidobacterium longum. The total number of beneficial microorganisms is 14 billion per capsule. In addition to Saccharomyces, lacto- and bifidobacteria, Lotardi-A includes the prebiotic component fructooligosaccharides and the enzyme alpha-amylase, which plays a crucial role in nourishing beneficial microorganisms in the gut.

Due to its unique composition, Lotardi-A has a step-by-step ecological action on the gut, creating optimal conditions for the growth and development of the gut's own microbiota. It compensates for the deficiency of beneficial microorganisms, normalizes the gastrointestinal tract's condition, and prevents inflammatory processes in the gut.

Lotardi-A can be recommended for any conditions that may be accompanied by an imbalance of gut microbiota, in particular antibiotic intake, chronic fatigue syndrome, acute and chronic gastrointestinal diseases, prevention of traveller’s diarrhea, and many others.

LOTARDI-A is a unique symbiotic complex for the protection and restoration of gut microbiota.